Kesler Norman & Wride’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.3M | Buy |
5,512
+255
| +5% | +$199K | 0.76% | 47 |
|
|
2025
Q1 | $4.34M | Buy |
5,257
+483
| +10% | +$399K | 0.83% | 43 |
|
|
2024
Q4 | $3.69M | Buy |
4,774
+760
| +19% | +$587K | 0.8% | 43 |
|
|
2024
Q3 | $3.56M | Buy |
4,014
+372
| +10% | +$330K | 0.7% | 48 |
|
|
2024
Q2 | $3.3M | Buy |
3,642
+657
| +22% | +$595K | 0.7% | 49 |
|
|
2024
Q1 | $2.32M | Buy |
2,985
+2,263
| +313% | +$1.76M | 0.49% | 67 |
|
|
2023
Q4 | $421K | Buy |
+722
| New | +$421K | 0.1% | 132 |
|